| Eric Lazar, MD | |
|
99 Beauvoir Ave, Summit, NJ 07901-3533 | |
| (973) 971-5595 | |
| Not Available |
| Full Name | Eric Lazar |
|---|---|
| Gender | Male |
| Speciality | Surgery - Pediatric Surgery |
| Location | 99 Beauvoir Ave, Summit, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558334862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0120X | Surgery - Pediatric Surgery | 25MA07674300 (New Jersey) | Primary |
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Hops, those little cone-shaped buds that give beer its bitter flavor, pack a surprisingly healthful punch. They are widely studied for their ability to halt bacterial growth and disease. Now, researchers report that they are close to synthesizing the healthful hops compounds in the lab. This advance could one day help scientists create medicines from these compounds without having to extract them from plants.
Neurosurgeons in the U.S. have begun the first of many operations to separate 3-year-old twins who are joined at the head.
VIVUS, Inc. today announced that on August 31, 2011, during the late breaking poster session at the 29th International Epilepsy Congress in Rome, Italy, Dr. Alison Pack, Associate Professor of Clinical Neurology, Department of Neurology, Columbia University Medical Center, will present the results of a retrospective study of medical claims data on oral clefts (OC) and major congenital malformations (MCMs) associated with in utero topiramate exposure.
Despite lower rates of traumatic brain injuries in baseball and softball, there is poor compliance overall with helmet use and return-to-play guidelines following a concussion across all levels of play, according to a new systematic review.
Amgen today announced results from a small, randomized, placebo-controlled Phase 2 study indicating that adding AMG 479 to gemcitabine improved overall survival at six months (primary endpoint) and progression-free survival in patients with metastatic pancreatic cancer. The study, which also included a separate arm of conatumumab plus gemcitabine, is being presented in a Poster Discussion at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting.
› Verified 6 days ago
| Entity Name | Valley Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467815928 PECOS PAC ID: 3577857333 Enrollment ID: O20160802002824 |
News Archive
Hops, those little cone-shaped buds that give beer its bitter flavor, pack a surprisingly healthful punch. They are widely studied for their ability to halt bacterial growth and disease. Now, researchers report that they are close to synthesizing the healthful hops compounds in the lab. This advance could one day help scientists create medicines from these compounds without having to extract them from plants.
Neurosurgeons in the U.S. have begun the first of many operations to separate 3-year-old twins who are joined at the head.
VIVUS, Inc. today announced that on August 31, 2011, during the late breaking poster session at the 29th International Epilepsy Congress in Rome, Italy, Dr. Alison Pack, Associate Professor of Clinical Neurology, Department of Neurology, Columbia University Medical Center, will present the results of a retrospective study of medical claims data on oral clefts (OC) and major congenital malformations (MCMs) associated with in utero topiramate exposure.
Despite lower rates of traumatic brain injuries in baseball and softball, there is poor compliance overall with helmet use and return-to-play guidelines following a concussion across all levels of play, according to a new systematic review.
Amgen today announced results from a small, randomized, placebo-controlled Phase 2 study indicating that adding AMG 479 to gemcitabine improved overall survival at six months (primary endpoint) and progression-free survival in patients with metastatic pancreatic cancer. The study, which also included a separate arm of conatumumab plus gemcitabine, is being presented in a Poster Discussion at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Lazar, MD Po Box 23831, Newark, NJ 07189-0001 Ph: (973) 971-5595 | Eric Lazar, MD 99 Beauvoir Ave, Summit, NJ 07901-3533 Ph: (973) 971-5595 |
News Archive
Hops, those little cone-shaped buds that give beer its bitter flavor, pack a surprisingly healthful punch. They are widely studied for their ability to halt bacterial growth and disease. Now, researchers report that they are close to synthesizing the healthful hops compounds in the lab. This advance could one day help scientists create medicines from these compounds without having to extract them from plants.
Neurosurgeons in the U.S. have begun the first of many operations to separate 3-year-old twins who are joined at the head.
VIVUS, Inc. today announced that on August 31, 2011, during the late breaking poster session at the 29th International Epilepsy Congress in Rome, Italy, Dr. Alison Pack, Associate Professor of Clinical Neurology, Department of Neurology, Columbia University Medical Center, will present the results of a retrospective study of medical claims data on oral clefts (OC) and major congenital malformations (MCMs) associated with in utero topiramate exposure.
Despite lower rates of traumatic brain injuries in baseball and softball, there is poor compliance overall with helmet use and return-to-play guidelines following a concussion across all levels of play, according to a new systematic review.
Amgen today announced results from a small, randomized, placebo-controlled Phase 2 study indicating that adding AMG 479 to gemcitabine improved overall survival at six months (primary endpoint) and progression-free survival in patients with metastatic pancreatic cancer. The study, which also included a separate arm of conatumumab plus gemcitabine, is being presented in a Poster Discussion at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting.
› Verified 6 days ago
Dr. David Daniels, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 33 Overlook Rd, Suite 302, Summit, NJ 07901 Phone: 908-598-8222 Fax: 908-598-8222 | |
Kerry Bergman, MD Surgery Medicare: Medicare Enrolled Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 973-971-7185 | |
James Gardner, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 Overlook Rd, Suite 310, Summit, NJ 07901 Phone: 908-918-1969 Fax: 908-918-1995 | |
Dr. Aaron T Miller, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 Overlook Rd, Suite 412, Summit, NJ 07901 Phone: 908-598-0220 Fax: 908-598-0415 | |
Dr. Stancie C. Rhodes, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Springfield Avenue, Suite 3a, Summit, NJ 07901 Phone: 908-202-6942 | |
Stephen C Hall, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 Overlook Rd, Suite 205, Summit, NJ 07901 Phone: 908-522-4500 Fax: 908-522-1222 |